Sale!

CST3 Gene Cerebral Amyloid Angiopathy Genetic Test

4,400 د.إ

-21%

The CST3 Gene Cerebral Amyloid Angiopathy Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the CST3 gene, which are linked to an increased risk of cerebral amyloid angiopathy (CAA). CAA is a neurological condition characterized by the accumulation of amyloid proteins in the walls of the blood vessels in the brain, leading to various complications such as hemorrhagic stroke, dementia, and cognitive decline. The test is particularly crucial for individuals with a family history of CAA or related symptoms, as early detection can significantly aid in managing the condition and tailoring appropriate treatment strategies. Priced at 4400 AED, this genetic test offers a valuable tool for patients and healthcare providers to understand the genetic predisposition to CAA, enabling proactive healthcare measures. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing outcomes, contributing to the advancement of personalized medicine in the region.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CST3 Gene Cerebral amyloid angiopathy Genetic Test

At DNA Labs UAE, we offer the CST3 Gene Cerebral amyloid angiopathy Genetic Test at a cost of AED 4400.0. This test is designed to diagnose and provide information about the risk of developing cerebral amyloid angiopathy, a condition characterized by the accumulation of amyloid protein in the walls of blood vessels in the brain.

Test Components

  • Price: AED 4400.0

Sample Condition

The sample required for this test can be either blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The test report will be delivered within 3 to 4 weeks.

Method

The CST3 Gene Cerebral amyloid angiopathy Genetic Test utilizes NGS (next-generation sequencing) technology.

Test Type

This test falls under the category of Neurological Disorders.

Doctor

This test is conducted by a Neurologist.

Test Department

The CST3 Gene Cerebral amyloid angiopathy Genetic Test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the CST3 Gene Cerebral amyloid angiopathy NGS Genetic DNA Test, it is recommended to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with CST3 Gene Cerebral amyloid angiopathy.

Test Details

The CST3 gene is associated with cerebral amyloid angiopathy, a condition characterized by the accumulation of amyloid protein in the walls of blood vessels in the brain. This can result in damage to the blood vessels and impairments in cognitive function.

NGS genetic testing is used to analyze the CST3 gene and identify any mutations or variations that may be associated with cerebral amyloid angiopathy. This type of testing aids in the diagnosis of the condition and provides information about the risk of developing it in the future. It can also guide treatment and management strategies for individuals with cerebral amyloid angiopathy.

Test Name CST3 Gene Cerebral amyloid angiopathy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CST3 Gene Cerebral amyloid angiopathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CST3 Gene Cerebral amyloid angiopathy
Test Details

The CST3 gene is associated with cerebral amyloid angiopathy, which is a condition characterized by the accumulation of amyloid protein in the walls of blood vessels in the brain. This can lead to damage to the blood vessels and impairments in cognitive function.

NGS (next-generation sequencing) genetic testing can be used to analyze the CST3 gene and identify any mutations or variations that may be associated with cerebral amyloid angiopathy. This type of testing can help to diagnose the condition and provide information about the risk of developing it in the future. It may also be used to guide treatment and management strategies for individuals with cerebral amyloid angiopathy.